Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Centessa Pharmaceuticals plc - American Depositary Shares (NQ:CNTA)

39.68 -0.18 (-0.45%)
Streaming Delayed Price Updated: 9:41 AM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 296,273
Open 39.70
Bid (Size) 39.66 (100)
Ask (Size) 39.70 (300)
Prev. Close 39.86
Today's Range 39.65 - 39.82
52wk Range 9.600 - 40.26
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Halper Sadeh LLC is Investigating Whether APLS, CNTA, EQH, VYNE are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Wall Street Ends a Rough Quarter With Its Best Day, Iran Hope Ignites the Rally ↗
Via Chartmill

Performance

YTD
+67.5%
+67.5%
1 Month
+49.7%
+49.7%
3 Month
+58.7%
+58.7%
6 Month
+75.4%
+75.4%
1 Year
+199.9%
+199.9%

More News

Read More
News headline image
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Why Centessa Stock Soared Today ↗
Via The Motley Fool
News headline image
Halper Sadeh LLC is Investigating Whether APLS, CNTA, BIRD, WBD are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Which stocks are experiencing notable movement on Tuesday? ↗
Via Chartmill
The market is filled with gapping stocks in Tuesday's session. ↗
Via Chartmill
News headline image
The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals
Via Finterra
Topics Economy Initial Public Offering Intellectual Property
News headline image
The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience
Via Finterra
Topics Economy Intellectual Property
Discover the top movers in Tuesday's pre-market session. ↗
Via Chartmill
News headline image
CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline ↗
Via The Motley Fool
News headline image
Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
Via The Motley Fool
News headline image
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
From Centessa Pharmaceuticals plc
Via GlobeNewswire
News headline image
This Fund Locked In Gains With a $14.5 Million Biotech Exit Amid a Staggering Stock Rally ↗
Via The Motley Fool
Topics ETFs
News headline image
Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting
From Centessa Pharmaceuticals plc
Via GlobeNewswire
News headline image
This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗
Via The Motley Fool
News headline image
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications
From Centessa Pharmaceuticals plc
Via GlobeNewswire
News headline image
What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out ↗
Via The Motley Fool
News headline image
This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Centessa Pharmaceuticals plc - American Depositary Shares publicly traded?
Yes, Centessa Pharmaceuticals plc - American Depositary Shares is publicly traded.
What exchange does Centessa Pharmaceuticals plc - American Depositary Shares trade on?
Centessa Pharmaceuticals plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares?
The ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares is CNTA on the Nasdaq Stock Market
What is the current price of Centessa Pharmaceuticals plc - American Depositary Shares?
The current price of Centessa Pharmaceuticals plc - American Depositary Shares is 39.68
When was Centessa Pharmaceuticals plc - American Depositary Shares last traded?
The last trade of Centessa Pharmaceuticals plc - American Depositary Shares was at 04/02/26 09:41 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.